EUVIMEDEUVIMED entdecken
Crossref

Clinical heterogeneity and prognostic markers in head and neck Kimura disease: A retrospective study

Yifan Yang, Xue Zhang, Qi Zhong, Yang Zhang, Hongzhi Ma, Lizhen Hou, Shizhi He, Qian Shi, Ru Wang, Jugao Fang, Ling Feng

European Archives of Oto-Rhino-Laryngology · 2025

DOI: 10.1007/s00405-025-09680-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Yifan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Tong Ren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Beijin…. Hauptthemen laut MEDLINE: Kimura Disease, Angiolymphoid Hyperplasia with Eosinophilia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Beijing Hospitals Authority Youth Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Kimura disease (KD) is a rare, chronic inflammatory disorder that is typically located in the head and neck region. It is characterized by subcutaneous nodules, eosinophilia, and elevated IgE levels. Its unclear etiology and similarities to malignancies create diagnostic and therapeutic challenges. The purpose of this study is to share our treatment experience and explore prognostic factors associated with KD. METHODS: We collected data on KD patients treated at our hospital between June 2013 and May 2024. The data included the patients' demographics, clinical and laboratory profiles, radiological and pathological findings, treatments, and outcomes. Non-normal variables are presented as medians with ranges, and categorical variables are shown as frequencies. We performed statistical comparisons using Mann-Whitney U tests. RESULTS: This study analyzed 13 KD patients (median age 44 years, male-to-female ratio 9:4). All patients present with had head and neck lesions. 75.0% showed elevated peripheral eosinophilia, 77.8% had increased blood eosinophilia percentages, and all tested patients had elevated IgE levels. Treatments included surgical excision, glucocorticoids, methotrexate, low-dose radiotherapy, and observation. Remission was achieved in 76.9% of patients. Patients with poor outcomes had significantly higher absolute eosinophil counts (median: 1.77 vs. 0.90 × 10⁹/L, p = 0.04) and percentages (median: 21.4% vs. 12.2%, p = 0.03) than those with favorable outcomes. Imaging misdiagnosis occurred in 38.5% of patients, highlighting the superiority of histopathology for diagnosis. Urine abnormalities, mild renal dysfunction, and uncommon lesion sites were also observed. CONCLUSION: The clinical heterogeneity of KD requires multidisciplinary management. Pre-treatment eosinophilia is emerging as a prognostic marker. Future studies should prioritize the identification of biomarkers, kinetic surveillance, and targeted biologics in order to reduce recurrence and systemic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kimura DiseaseAngiolymphoid Hyperplasia with EosinophiliaHumansMaleFemaleRetrospective StudiesAdultPrognosisMiddle AgedYoung AdultImmunoglobulin EAgedNeckHeadAdolescentGlucocorticoidsEosinophilia

Stichwörter der Autor:innen

Diagnostic imagingEosinophiliaHead and neck neoplasmsKimura diseasePathological diagnosis

Substanzen

Immunoglobulin EGlucocorticoids

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Tong Ren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Beijing, 100730, China.
  • Key Laboratory of Otorhinolaryngology, Head and Neck Surgery, Beijing Institute of Otorhinolaryngology, No.1 Dongjiaominxiang Street, Beijing, 100730, China.
  • Department of Pathology, Beijing Tong Ren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Beijing, 100730, China.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Tong Ren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Beijing, 100730, China. fengling@ccmu.edu.cn.
  • Key Laboratory of Otorhinolaryngology, Head and Neck Surgery, Beijing Institute of Otorhinolaryngology, No.1 Dongjiaominxiang Street, Beijing, 100730, China. fengling@ccmu.edu.cn.

Förderung

  • Beijing Natural Science Foundation
  • Beijing Hospitals Authority Youth Programme

Zitieren

APA

Yang, Y., Zhang, X., Zhong, Q., Zhang, Y., Ma, H., Hou, L., He, S., Shi, Q., Wang, R., Fang, J., & Feng, L. (2025). Clinical heterogeneity and prognostic markers in head and neck Kimura disease: A retrospective study. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-025-09680-7

Vancouver

Yang Y, Zhang X, Zhong Q, Zhang Y, Ma H, Hou L, et al. Clinical heterogeneity and prognostic markers in head and neck Kimura disease: A retrospective study. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-025-09680-7

BibTeX
@article{Yang2025,
  author = {Yang, Yifan and Zhang, Xue and Zhong, Qi and Zhang, Yang and Ma, Hongzhi and Hou, Lizhen and He, Shizhi and Shi, Qian and Wang, Ru and Fang, Jugao and Feng, Ling},
  title = {Clinical heterogeneity and prognostic markers in head and neck Kimura disease: A retrospective study},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2025},
  doi = {10.1007/s00405-025-09680-7}
}
Kostenlos starten →